Although we can affirm the existence of a negative role of IL-33 in CML and in lymphoproliferative diseases and positive in pathologies like AML, the action of IL-33 seems to be multiple and sometimes contradictory within the same pathology. Here, IL33 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.